Case number IPR2017-00823
Coherus BioSciences, Inc. v. AbbVie Biotechnology Ltd. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Dec 1, 2017 | 16 | Notice of Refund Download | |
| Nov 29, 2017 | 15 | Petitioner's Request for Refund of Post-Institution Fee Download | |
| Sep 7, 2017 | 14 | Decision Denying Institution of Inter Partes Review Download | |
| Jun 11, 2017 | 12 | Patent Owner's Updated Mandatory Notices Download | |
| Jun 11, 2017 | 13 | Patent Owner's Preliminary Response Download | |
| Jun 11, 2017 | 2055 | ZEVALIN Label Download | |
| Jun 11, 2017 | 2028 | Rouet 2014 Download | |
| Jun 11, 2017 | 2021 | Daugherty 2006 Download | |
| Jun 11, 2017 | 2047 | Wang 2007 Download | |
| Jun 11, 2017 | 11 | Patent Owner's Updated Power of Attorney Download | |
| Jun 11, 2017 | 2042 | Humphreys 2015 Download | |
| Jun 11, 2017 | 2051 | Shire 2015 Download | |
| Apr 10, 2017 | 10 | REPLACEMENT PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619 PURSUANT TO 35 U.S.C. ¿¿¿¿ 311¿¿¿319 AND 37 C.F.R. ¿¿ 42 Download | |
| Apr 10, 2017 | 1102 | Replacement Exhibit 1102 - Radtke Declaration Download | |
| Apr 10, 2017 | 1105 | Replacement Exhibit 1105 - Humira in PDR 2004 Download | |
| Apr 10, 2017 | 1108 | Replacement Exhibit 1108 - Gamimune in PDR 2002 Download | |
| Apr 7, 2017 | 9 | Order Conduct of the Proceeding Download | |
| Mar 23, 2017 | 8 | Petitioner's Updated Mandatory Notices Download | |
| Mar 17, 2017 | 7 | Patent Owner's Second Updated Mandatory Notices Download | |
| Feb 27, 2017 | 6 | Patent Owner's Updated Mandatory Notices Download | |
| Feb 24, 2017 | 5 | Notice of Accord Filing Date Download | |
| Feb 21, 2017 | 3 | Patent Owner's Power of Attorney Download | |
| Feb 21, 2017 | 4 | Patent Owner's Mandatory Notices Download | |
| Jan 31, 2017 | 1113 | AbbVie Biotechnology Ltd., ¿¿¿Annex A ¿¿¿ The Humira¿¿ Story,¿¿¿ Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download | |
| Jan 31, 2017 | 1108 | GAMIMUNE¿¿ Label (Oct. 2005) Download | |
| Jan 31, 2017 | 1143 | GAMMAGARD LIQUID Label (April 2005) Download | |
| Jan 31, 2017 | 1116 | Gokarn et al., ¿¿¿Excipients for Protein Drugs,¿¿¿ Download | |
| Jan 31, 2017 | 1153 | Akers et al., ¿¿¿Formulation Development of Protein Dosage Forms,¿¿¿ Download | |
| Jan 31, 2017 | 1159 | Frenken et al., ¿¿¿Identification of the Component Part in an Epoetin Alfa Preparation that Causes Pain after Subcutaneous Injection,¿¿¿ Download | |
| Jan 31, 2017 | 1109 | SYNAGIS¿¿ Label (July 2004) Download | |
| Jan 31, 2017 | 2 | PETITIONER'S POWER OF ATTORNEY PURSUANT TO 37 CFR 42.lO(b) Download | |
| Jan 31, 2017 | 1156 | Handbook of Pharmaceutical Excipients Download | |
| Jan 31, 2017 | 1104 | U.S. App. 60/690,582 to Gokarn et al. Download | |
| Jan 31, 2017 | 1134 | U.S. Pub. No. 2012/0028877 Download | |
| Jan 31, 2017 | 1135 | U.S. Pub. No. 2008/0311078 Download | |
| Jan 31, 2017 | 1123 | U.S. Prosecution History of App. No. 13/774,735 (Part 2) Download | |
| Jan 31, 2017 | 1128 | Schwartz, ¿¿¿Diafiltration for Desalting of Buffer Exchange,¿¿¿ BioProcess Int¿¿¿l Download | |
| Jan 31, 2017 | 1119 | Olthuis et al., ¿¿¿Characterization of Proteins by Means of their Buffer Capacity..." Download | |
| Jan 31, 2017 | 1115 | Van Slyke, ¿¿¿On the Measurement of Buffer Values and on the..." Download | |
| Jan 31, 2017 | 1142 | CNJ-016 (Vaccinia Immune Globulin Intravenous) Label (Jan. 2010) Download | |
| Jan 31, 2017 | 1107 | Adalimumab Product Approval Information Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download | |
| Jan 31, 2017 | 1136 | WO 2006/138181 Download | |
| Jan 31, 2017 | 1111 | TYSABRI¿¿ Label (Nov. 2004) Download | |
| Jan 31, 2017 | 1122 | U.S. Prosecution History of App. No. 14/506,576 Download | |
| Jan 31, 2017 | 1138 | WO 1997/029131 Download | |
| Jan 31, 2017 | 1150 | Butler & Hamilton, ¿¿¿Quantitation of Specific Antibodies: Methods of Express, Standards, Solid-Phase Considerations, and Specific Applications,¿¿¿ Download | |
| Jan 31, 2017 | 1152 | McDonnell, ¿¿¿Production of Antibodies in Hybridoma and Non-hybridoma Cell Lines,¿¿¿ Download | |
| Jan 31, 2017 | 1158 | Laursen et al., “Pain Perception after Subcutaneous Injections of Media Containing Different Buffers,” Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download | |
| Jan 31, 2017 | 1146 | GAMUNEX¿¿ Label (Nov. 2005) Download | |
| Jan 31, 2017 | 1145 | Flebogamma¿¿ Label (Jan. 2004) Download | |
| Jan 31, 2017 | 1117 | Fransson & Espander-Jansson, ¿¿¿Local Tolerance of Subcutaneous Injections,¿¿¿ Download | |
| Jan 31, 2017 | 1133 | U.S. Pub. No. 2013/0273066 Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download | |
| Jan 31, 2017 | 1 | PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619 PURSUANT TO 35 U.S.C. ¿¿¿¿ 311¿¿¿319 AND 37 C.F.R. ¿¿ 42 Download | |
| Jan 31, 2017 | 1112 | AbbVie Biotechnology Ltd., ¿¿¿Patent Owner¿¿¿s Preliminary Response,¿¿¿ Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download | |
| Jan 31, 2017 | 1144 | OCTAGAM¿¿ Label (Mar. 2004) Download | |
| Jan 31, 2017 | 1137 | U.S. Patent No. 6,090,382 Download | |
| Jan 31, 2017 | 1123 | U.S. Prosecution History of App. No. 13/774,735 (Part 2) Download | |
| Jan 31, 2017 | 1127 | ¿¿¿Fraunhofer Substantive Motion 3,¿¿¿ in Fraunhofer v. Gokarn, Patent Interference No. 106,057 Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 1) Download | |
| Jan 31, 2017 | 1132 | Press Release Download | |
| Jan 31, 2017 | 1139 | HUMIRA¿¿ Label (Nov. 2015) Download | |
| Jan 31, 2017 | 1118 | Nozaki & Tanford, ¿¿¿Examination of Titration Behavior,¿¿¿ Download | |
| Jan 31, 2017 | 1126 | Stoner et al., ¿¿¿Protein¿¿¿Solute Interactions Affect the Outcome..." Download | |
| Jan 31, 2017 | 1160 | Gelfand, ¿¿¿Differences Between IGIV Products: Impact on Clinical Outcome,¿¿¿ Download | |
| Jan 31, 2017 | 1151 | Jefferis et al., ¿¿¿Recognition Sites on Human IgG for Fc¿¿ Receptors: The Role of Glycosylation,¿¿¿ Download | |
| Jan 31, 2017 | 1148 | HepaGam BTM Summary Basis for Approval (Jan. 2006) Download | |
| Jan 31, 2017 | 1101 | U.S. Patent No. 9,085,619 Download | |
| Jan 31, 2017 | 1102 | Declaration of Klaus-Peter Radtke, Ph.D. Download | |
| Jan 31, 2017 | 1131 | Carnahan et al., ¿¿¿Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22: Characterization of In Vitro Properties,¿¿¿ Download | |
| Jan 31, 2017 | 1130 | Gebhart, ¿¿¿Biotech Company Preparing Several Drugs for Takeoff,¿¿¿ Download | |
| Jan 31, 2017 | 1157 | U.S. Pub. No. 2003/0138417 Download | |
| Jan 31, 2017 | 1103 | U.S. Pub. No. 2016/0319011, Gokarn et al. Download | |
| Jan 31, 2017 | 1110 | AVASTINTM Label (Feb. 2004) Download | |
| Jan 31, 2017 | 1141 | Vivaglobin¿¿ Label (Jan. 2006) Download | |
| Jan 31, 2017 | 1106 | HUMIRA¿¿ Label (Jan. 2008) Download | |
| Jan 31, 2017 | 1129 | U.S. Pub. No. 2004/0033535, Boyle et al. Download | |
| Jan 31, 2017 | 1161 | Campath¿¿ Label (Aug. 2006) Download | |
| Jan 31, 2017 | 1149 | VectibixTM Label (Sept. 2006) Download | |
| Jan 31, 2017 | 1125 | U.S. Prosecution History of App. No. 61/004,992 Download | |
| Jan 31, 2017 | 1120 | Physicians¿¿¿ Desk Reference, pp. 558-59, 914-31, 805-07, 2026-28, 2295-97, 2524-25 (56th ed. 2002) Download | |
| Jan 31, 2017 | 1121 | Parslow, ¿¿¿Immunoglobulins & Immunoglobulin Genes,¿¿¿ Download | |
| Jan 31, 2017 | 1105 | HUMIRA¿¿ Label (Jan. 2003) Download | |
| Jan 31, 2017 | 1114 | Christensen, ¿¿¿Proteins as buffers,¿¿¿ Download | |
| Jan 31, 2017 | 1155 | Hanna, The IGIV-C Study Group, ¿¿¿Tolerability of a New Intravenous Immunoglobulin Preparation (IGIV) in Pediatric and Adult Patients,¿¿¿ Download | |
| Jan 31, 2017 | 1140 | HUMIRA¿¿ Label (Oct. 2016) Download | |
| Jan 31, 2017 | 1147 | Privigen¿¿ Label (Oct. 2016) Download | |
| Jan 31, 2017 | 1154 | Cleland & Langer, ¿¿¿Formulation and Delivery of Proteins and Peptides: Design and Development Strategies,¿¿¿ Download | |
| Jan 31, 2017 | 1105 | HUMIRA¿¿ Label (Jan. 2003) Download | |
| Jan 31, 2017 | 1102 | Declaration of Klaus-Peter Radtke, Ph.D. Download | |
| Jan 31, 2017 | 1108 | GAMIMUNE¿¿ Label (Oct. 2005) Download | |
| Jan 31, 2017 | 1123 | U.S. Prosecution History of App. No. 13/774,735 (Part 1) Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 2) Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 6) Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 3) Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 4) Download | |
| Jan 31, 2017 | 1124 | U.S. Prosecution History of App. No. 12/325,049 (Part 5) Download |
